pH-Responsive Nanosuspension Based on an Orthoester for Synergistic Chemodynamic and Photothermal Therapy in Localized Cancer Treatment
Lists
Only you see this
Abstract
This study aims to develop a pH-responsive nanosuspension for localized cancer therapy by integrating photothermal therapy (PTT) and chemodynamic therapy (CDT). Initially, we synthesized a compound containing two five-membered cyclic orthoester bonds (OE) as a liquid pharmaceutical excipient. This OE was subsequently coloaded with the photothermal agent indocyanine green (ICG) and iron oxide nanoparticles (Fe<sub>3</sub>O<sub>4</sub>), forming a stable nanosuspension (OE/ICG/Fe<sub>3</sub>O<sub>4</sub>). OE exhibits acid-sensitive degradation, enabling controlled drug release in the tumor microenvironment. The Fe<sub>3</sub>O<sub>4</sub> nanoparticles can induce the generation of reactive oxygen species (ROS) through the Fenton reaction, which synergizes effectively with the photothermal effect of ICG. Additionally, the OE/ICG/Fe<sub>3</sub>O<sub>4</sub> formulation prolongs drug retention in tumor tissues and enhances drug penetration. Furthermore, the formulation induces immune modulation via Fe<sub>3</sub>O<sub>4</sub>, thereby enhancing the overall therapeutic efficacy. Under 808 nm near-infrared laser irradiation, a tumor suppression rate of 84.6% was achieved through the combination of photothermal and chemodynamic therapies and immunotherapy. This study highlights the potential of OE-based nanosuspensions for localized cancer treatment, offering a multifunctional strategy to improve treatment outcomes while minimizing systemic toxicity.
BibTeX
@inproceedings{hu2025ph,
author = {Junjie Hu and Chengqi Zhang and Hao Xu and Yi Wan and Xin Wang and Rupei Tang},
title = {{pH-Responsive Nanosuspension Based on an Orthoester for Synergistic Chemodynamic and Photothermal Therapy in Localized Cancer Treatment}},
booktitle = {ACS},
year = {2025},
doi = {10.1021/acsabm.5c00578},
}Loading related content...